The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bjornsson, T. D., Callaghan, J. T., Einolf, H. J., Fischer, V., Gan, L., Grimm, S., Kao, J., King, S. P., Miwa, G., Ni, L., et al. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.7.815 · Cited by 792
Torsades de Pointes Occurring in Association With Terfenadine Use
Monahan, B. P. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450210088038 · Cited by 667
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7
Williams, J. A., Ring, B. J., Cantrell, V. E., Jones, D. R., Eckstein, J., Ruterbories, K., Hamman, M. A., Hall, S. D., & Wrighton, S. A. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.8.883 · Cited by 471
Self-citationDrug glucuronidation in humans
Miners, J. O., & Mackenzie, P. I. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90065-t · Cited by 361
Court, M. H., Duan, S. X., von Moltke, L. L., Greenblatt, D. J., Patten, C. J., Miners, J. O., & Mackenzie, P. I. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29222-3 · Cited by 301
Transport of organic anions across the basolateral membrane of proximal tubule cells
Burckhardt, B. C., & Burckhardt, G. (2003) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-002-0003-8 · Cited by 294
Mechanistic Studies on Metabolic Interactions between Gemfibrozil and Statins
Prueksaritanont, T., Zhao, J. J., Ma, B., Roadcap, B. A., Tang, C., Qiu, Y., Liu, L., Lin, J. H., Pearson, P. G., & Baillie, T. A. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1042 · Cited by 287
Green, M. D., King, C. D., Mojarrabi, B., Mackenzie, P. I., & Tephly, T. R. (1998) · PubMed · Cited by 253
Court, M. H., Krishnaswamy, S., Hao, Q., Duan, S. X., Patten, C. J., von Moltke, L. L., & Greenblatt, D. J. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.9.1125 · Cited by 251
Jin, C., Miners, J. O., Lillywhite, K. J., & Mackenzie, P. I. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10294-2 · Cited by 226
Cited by
Cytochrome P450 and Chemical Toxicology
Guengerich, F. P. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700079z · Cited by 1,725
Predicting in vivo drug interactions from in vitro drug discovery data
Wienkers, L. C., & Heath, T. G. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1851 · Cited by 904
ADMET-score – a comprehensive scoring function for evaluation of chemical drug-likeness
Guan, L., Yang, H., Cai, Y., Sun, L., Di, P., Li, W., Liu, G., & Tang, Y. (2019) · MedChemComm · doi:10.1039/c8md00472b · Cited by 712
The UDP-glucuronosyltransferases: Their role in drug metabolism and detoxification
Rowland, A., Miners, J. O., & Mackenzie, P. I. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.02.019 · Cited by 709
Cobbina, E., & Akhlaghi, F. (2017) · Drug Metabolism Reviews · doi:10.1080/03602532.2017.1293683 · Cited by 653
Cytochrome P450s and other enzymes in drug metabolism and toxicity
Guengerich, F. P. (2006) · The AAPS Journal · doi:10.1208/aapsj080112 · Cited by 624
UDP-glucuronosyltransferases and clinical drug-drug interactions
KIANG, T., ENSOM, M., & CHANG, T. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.10.013 · Cited by 552
Rendic, S., & Guengerich, F. P. (2015) · Chemical Research in Toxicology · doi:10.1021/tx500444e · Cited by 477
Pharmacogenetics, Pharmacogenomics, and Individualized Medicine
Ma, Q., & Lu, A. Y. H. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003533 · Cited by 464
Halogen Bond: Its Role beyond Drug–Target Binding Affinity for Drug Discovery and Development
Xu, Z., Yang, Z., Liu, Y., Lu, Y., Chen, K., & Zhu, W. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci400539q · Cited by 431
The ontogeny of drug metabolism enzymes and implications for adverse drug events
Hines, R. N. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.02.005 · Cited by 410
Recent Structural Insights into Cytochrome P450 Function
Guengerich, F. P., Waterman, M. R., & Egli, M. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.05.006 · Cited by 383
Measurement of cytochrome P450 and NADPH–cytochrome P450 reductase
Guengerich, F. P., Martin, M. V., Sohl, C. D., & Cheng, Q. (2009) · Nature Protocols · doi:10.1038/nprot.2009.121 · Cited by 378
Developmental Pharmacokinetics in Pediatric Populations
Lu, H., & Rosenbaum, S. (2014) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-19.4.262 · Cited by 358
Antiepileptic drug interactions—Principles and clinical implications
I. Johannessen, S., & Johannessen Landmark, C. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246254 · Cited by 343
Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS)
Varma, M. V., Steyn, S. J., Allerton, C., & El-Kattan, A. F. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1749-4 · Cited by 334
Toward in silico structure-based ADMET prediction in drug discovery
Moroy, G., Martiny, V. Y., Vayer, P., Villoutreix, B. O., & Miteva, M. A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.10.023 · Cited by 302
Zhang, D., Chando, T. J., Everett, D. W., Patten, C. J., Dehal, S. S., & Humphreys, W. G. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005447 · Cited by 286
Contributions of Human Enzymes in Carcinogen Metabolism
Rendic, S., & Guengerich, F. P. (2012) · Chemical Research in Toxicology · doi:10.1021/tx300132k · Cited by 279
Kassahun, K., McIntosh, I., Cui, D., Hreniuk, D., Merschman, S., Lasseter, K., Azrolan, N., Iwamoto, M., Wagner, J. A., & Wenning, L. A. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.016196 · Cited by 278
Fenner, K., Troutman, M., Kempshall, S., Cook, J., Ware, J., Smith, D., & Lee, C. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.195 · Cited by 272
Self-citationKang, J.-Y., Kim, S.-Y., Kim, D., Kim, D.-H., Shin, S.-M., Park, S.-H., Kim, K.-H., Jung, H.-C., Pan, J.-G., Joung, Y. H., et al. (2011) · AMB Express · doi:10.1186/2191-0855-1-1 · Cited by 256
Zamek-Gliszczynski, M. J., Hoffmaster, K. A., Nezasa, K.-I., Tallman, M. N., & Brouwer, K. L. R. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.12.007 · Cited by 256
Reactions and enzymes in the metabolism of drugs and other xenobiotics
Testa, B., Pedretti, A., & Vistoli, G. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.01.017 · Cited by 254
Yu, K., Geng, X., Chen, M., Zhang, J., Wang, B., Ilic, K., & Tong, W. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.056267 · Cited by 150
Argikar, U. A., Potter, P. M., Hutzler, J. M., & Marathe, P. H. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9962-6 · Cited by 89
Komura, H., & Iwaki, M. (2011) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.597401 · Cited by 78
Ferl, G. Z., Theil, F., & Wong, H. (2016) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1994 · Cited by 54
Predicting Mouse Liver Microsomal Stability with “Pruned” Machine Learning Models and Public Data
Perryman, A. L., Stratton, T. P., Ekins, S., & Freundlich, J. S. (2016) · Pharmaceutical Research · doi:10.1007/s11095-015-1800-5 · Cited by 50
Development of a Dynamic Physiologically Based Mechanistic Kidney Model to Predict Renal Clearance
Huang, W., & Isoherranen, N. (2018) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12321 · Cited by 49
The effects of fasting on drug metabolism
Lammers, L. A., Achterbergh, R., Mathôt, R. A. A., & Romijn, J. A. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1706728 · Cited by 32
“UGTs represent the majority of phase II metabolizing enzymes.”
BackgroundNegoro, R., Tasaka, M., Deguchi, S., Takayama, K., & Fujita, T. (2022) · Cells · doi:10.3390/cells11101677 · Cited by 16
Metadata
- Authors
- Williams, J. A., Hyland, R., Jones, B. C., Smith, D. A., Hurst, S., Goosen, T. C., Peterkin, V., Koup, J. R., & Ball, S. E.
- Venue
- Drug Metabolism and Disposition
- Publisher
- Elsevier BV
- Published
- 2004-11
- Volume
- 32
- Issue
- 11
- Pages
- 1201-1208
- ISSN
- 0090-9556 (ISSN-L)
- OpenAlex
- W2115763439
- Cited by
- 928
- References
- 48
- FWCI
- 15.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.